Cutler Group LP Novartis Ag Call Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 07, 2023	BUY	$75.55 - $92.52 $861,270 - $1.05 Million	11,400 Added 178.13%	17,800 $282,000
Q3 2022 Oct 25, 2022	BUY	$74.61 - $87.26 $111,915 - $130,890	1,500 Added 30.61%	6,400 $15,000
Q2 2022 Aug 04, 2022	SELL	$80.52 - $93.75 $756,888 - $881,250	-9,400 Reduced 65.73%	4,900 $8,000
Q1 2022 Apr 14, 2022	BUY	$80.11 - $90.62 $761,045 - $860,890	9,500 Added 197.92%	14,300 $55,000
Q2 2019 Aug 09, 2019	SELL	$75.4 - $92.8 $15,080 - $18,560	-200 Reduced 4.0%	4,800 $23,000
Q1 2019 May 10, 2019	BUY	$75.32 - $86.15 $376,599 - $430,750	5,000 New	5,000 $32,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.